BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10694618)

  • 1. Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances.
    Massoudy P; Zahler S; Freyholdt T; Henze R; Barankay A; Becker BF; Braun SL; Meisner H
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):566-74. PubMed ID: 10694618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action.
    Massoudy P; Zahler S; Barankay A; Becker BF; Richter JA; Meisner H
    Ann Thorac Surg; 1999 Apr; 67(4):1059-64. PubMed ID: 10320251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of sodium nitroprusside after coronary artery bypass surgery: pump function correlates inversely with cardiac release of proinflammatory cytokines.
    Freyholdt T; Massoudy P; Zahler S; Henze R; Barankay A; Becker BF; Meisner H
    J Cardiovasc Pharmacol; 2003 Sep; 42(3):372-8. PubMed ID: 12960682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass.
    Massoudy P; Zahler S; Becker BF; Braun SL; Barankay A; Meisner H
    Chest; 2001 Jan; 119(1):31-6. PubMed ID: 11157581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.
    Wan S; DeSmet JM; Barvais L; Goldstein M; Vincent JL; LeClerc JL
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):806-11. PubMed ID: 8800171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting.
    Deng MC; Dasch B; Erren M; Möllhoff T; Scheld HH
    Ann Thorac Surg; 1996 Jul; 62(1):184-90. PubMed ID: 8678641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.
    Wan S; Marchant A; DeSmet JM; Antoine M; Zhang H; Vachiery JL; Goldman M; Vincent JL; LeClerc JL
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):469-77. PubMed ID: 8583822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza Vaccination Blunts the Inflammatory Response in Patients Undergoing Cardiopulmonary Bypass.
    Atoui R; Ebrahim F; Saroka K; Mireau J; McElhaney JE; Hare GMT
    Ann Thorac Surg; 2021 Jun; 111(6):1923-1930. PubMed ID: 33038338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass.
    Zahler S; Massoudy P; Hartl H; Hähnel C; Meisner H; Becker BF
    Cardiovasc Res; 1999 Mar; 41(3):722-30. PubMed ID: 10435044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization.
    Hennein HA; Ebba H; Rodriguez JL; Merrick SH; Keith FM; Bronstein MH; Leung JM; Mangano DT; Greenfield LJ; Rankin JS
    J Thorac Cardiovasc Surg; 1994 Oct; 108(4):626-35. PubMed ID: 7934095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting.
    Wei M; Kuukasjärvi P; Laurikka J; Pehkonen E; Kaukinen S; Laine S; Tarkka M
    Cytokine; 2001 Aug; 15(4):223-8. PubMed ID: 11563882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of systemic inflammatory response with sodium nitroprusside in open heart surgery.
    Göl MK; Nisanoğlu V; Işcan Z; Balci M; Kandemir O; Taşdemir O
    J Cardiovasc Surg (Torino); 2002 Dec; 43(6):803-9. PubMed ID: 12483170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of pro-inflammatory cytokine levels and cellular adhesion in CABG procedures with separated pulmonary and systemic extracorporeal circulation without an oxygenator.
    Massoudy P; Zahler S; Tassani P; Becker BF; Richter JA; Pfauder M; Lange R; Meisner H
    Eur J Cardiothorac Surg; 2000 Jun; 17(6):729-36. PubMed ID: 10856868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
    Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
    Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
    Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10.
    Giomarelli P; Scolletta S; Borrelli E; Biagioli B
    Ann Thorac Surg; 2003 Jul; 76(1):117-23. PubMed ID: 12842524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury.
    Wan S; Izzat MB; Lee TW; Wan IY; Tang NL; Yim AP
    Ann Thorac Surg; 1999 Jul; 68(1):52-6; discussion 56-7. PubMed ID: 10421114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study.
    Roth M; Kraus B; Scheffold T; Reuthebuch O; Klövekorn WP; Bauer EP
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):642-50. PubMed ID: 11003743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations.
    Sawa Y; Shimazaki Y; Kadoba K; Masai T; Fukuda H; Ohata T; Taniguchi K; Matsuda H
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):29-35. PubMed ID: 8551786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The systemic inflammatory response in coronary artery bypass grafting: what is the role of the very low ejection fraction (EF < or = 30%)?
    Karfis EA; Papadopoulos G; Matsagas M; Pantazi D; Lekka M; Kitsiouli I; Siminelakis S; Anagnostopoulos C; Drossos G
    J Cardiovasc Surg (Torino); 2008 Dec; 49(6):801-8. PubMed ID: 19043394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.